MeiraGTx Holdings plc Asset Retirement Obligation, Liabilities Incurred
MeiraGTx Holdings plc (MGTX) reported Asset Retirement Obligation, Liabilities Incurred of $9.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-15.
Discontinued › Notes › Asset Retirement Obligations
us-gaap:AssetRetirementObligationLiabilitiesIncurred · last filed 2024-03-15
- MeiraGTx Holdings plc asset retirement obligation, liabilities incurred for the quarter ending 2022-12-31 was $1.00K.
- MeiraGTx Holdings plc asset retirement obligation, liabilities incurred for the quarter ending 2022-09-30 was -$1.00K.
- MeiraGTx Holdings plc asset retirement obligation, liabilities incurred for the quarter ending 2022-06-30 was -$1.00K.
- MeiraGTx Holdings plc asset retirement obligation, liabilities incurred for the quarter ending 2022-03-31 was $10.00K.
- MeiraGTx Holdings plc asset retirement obligation, liabilities incurred for fiscal 2022 was $9.00K, a 92.50% decline from fiscal 2021.
- MeiraGTx Holdings plc asset retirement obligation, liabilities incurred for fiscal 2021 was $120.00K.
- MeiraGTx Holdings plc asset retirement obligation, liabilities incurred for fiscal 2019 was $1.27M.
| Period end | Asset Retirement Obligation, Liabilities Incurred 3 month | Asset Retirement Obligation, Liabilities Incurred 6 month | Asset Retirement Obligation, Liabilities Incurred 9 month | Asset Retirement Obligation, Liabilities Incurred 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $0.00 derived: sum of 2 quarters · filed 2024-03-15 | -$1.00K derived: sum of 3 quarters · filed 2024-03-15 | $9.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$2.00K derived: sum of 2 quarters · filed 2023-11-14 | $8.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $9.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $120.00K 10-K · filed 2023-03-14 | |||
| 2019-12-31 | $1.27M 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |